Pricing Log in Create free account

WAVE Life Sciences Ltd. (WVE) vs Zevra Therapeutics, Inc. (ZVRA)

WAVE Life Sciences Ltd. and Zevra Therapeutics, Inc. are both Biotechnology companies. WAVE Life Sciences Ltd. and Zevra Therapeutics, Inc. are of similar size ($628.6M and $609.9M). WAVE Life Sciences Ltd. has negative trailing earnings, so its P/E is not meaningful; Zevra Therapeutics, Inc. trades at 10.5×. Zevra Therapeutics, Inc. grew revenue faster over the last twelve months: 119.4% against −30.4%. Zevra Therapeutics, Inc. has the higher net margin (42.3% vs −309.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Zevra Therapeutics, Inc. leads on 11 and WAVE Life Sciences Ltd. on 5.

Valuation

Metric WVE ZVRA Biotechnology median
P/E n/m 10.47 8.50
P/S 9.74 4.33 9.71
P/B 1.40 2.70 2.13
Price to free cash flow n/m 17.80 20.82
EV/EBITDA n/m 5.79 0.64
EV/Sales 2.23 3.43 9.21
Earnings yield (34.94%) 9.55% (33.15%)
Free cash flow yield (30.34%) 5.62% (25.50%)

Profitability

Metric WVE ZVRA Biotechnology median
Gross margin 100.00% 95.46% 65.16%
Operating margin (333.36%) 60.54% 0.00%
Net margin (309.73%) 42.25% 0.00%
Free cash flow margin (295.46%) 24.30% 0.00%
Return on equity (68.31%) 34.33% (56.36%)
Return on assets (49.95%) 20.57% (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric WVE ZVRA Biotechnology median
Revenue growth (TTM) (30.42%) 119.40% 6.02%
EPS growth (last fiscal year) (72.86%) 159.21% 30.26%
Revenue growth, 5-year CAGR 16.31% 51.62% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric WVE ZVRA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 9.99 5.17 4.72
Net debt to EBITDA 2.92 39.03 0.96

Dividend

Metric WVE ZVRA Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric WVE ZVRA Biotechnology median
Market cap 628.58m 609.88m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack